Letter/Comment
The latest advocacy letters and comments from the American Hospital Association.
AHA letter to Representative Charles Dent endorsing HR 3537, the Synthetic Drug Control Act of 2015.
AHA strongly supports many of the provisions of the Health Benefit Plan Network Access and Adequacy Model Act (Model Act) as approved by the National Association of Insurance Commissioners' (NAIC) Regulatory Framework (B) Task Force.
AHA Expresses Concern Re: H.R. 3298, the Medicare Post-Acute Care Value-Based Purchasing Act of 2015
AHA letter to House Committee on Ways and Means Subcommittee on Health expressing concerns regarding H.R. 3298, the Medicare Post-Acute Care Value-Based Purchasing (PAC VBP) Act of 2015.
AHA comments on the America's Health Insurance Plans' (AHIP) testimony for the House Judiciary Subcommittee on Regulatory Reform, Commercial and Antitrust Law's September 10, 2015 hearing on "The State of Competition in the Health Care Marketplace."